103 records – page 2 of 6.

Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations

https://policybase.cma.ca/link/policy11114
Date
2014-03-17
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety

https://policybase.cma.ca/link/policy11125
Date
2014-03-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase

https://policybase.cma.ca/link/policy11129
Date
2014-05-15
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

The Health risks and harms associated with the use of marijuana

https://policybase.cma.ca/link/policy11138
Date
2014-05-27
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Amendments to PIPEDA, Bill S-4

https://policybase.cma.ca/link/policy11194
Date
2014-06-09
Topics
Health information and e-health
Ethics and medical professionalism

Bill C-17 An Act to amend the Food and Drugs Act

https://policybase.cma.ca/link/policy11196
Date
2014-06-11
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Proposed amendments to the marihuana for medical purposes regulations

https://policybase.cma.ca/link/policy11293
Date
2014-07-11
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Tamper Resistance under the Controlled Drugs and Substances Act

https://policybase.cma.ca/link/policy11295
Date
2014-08-26
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11297
Date
2014-10-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Authorizing Cannabis for Medical Purposes

https://policybase.cma.ca/link/policy11514
Last Reviewed
2020-02-29
Date
2015-02-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Last Reviewed
2020-02-29
Date
2015-02-28
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail

Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)

https://policybase.cma.ca/link/policy11519
Date
2015-05-14
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Complementary and alternative medicine (update 2015)

https://policybase.cma.ca/link/policy11529
Date
2015-05-30
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
Policy Type
Policy document
Date
2015-05-30
Replaces
Complementary and alternative medicine (Update 2008)
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
Documents
Less detail

Harms associated with opioids and other psychoactive prescription drugs

https://policybase.cma.ca/link/policy11535
Date
2015-05-30
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA's Response to Health Canada's Public Consultation Guide to New Authorities in reference to Bill C-17, Protecting Canadians from Unsafe Drugs Act (Vanessa's Law)

https://policybase.cma.ca/link/policy11599
Date
2015-06-08
Topics
Pharmaceuticals, prescribing, cannabis, drugs

CMA’s formal submission to the Federal External Panel on assisted dying

https://policybase.cma.ca/link/policy11750
Last Reviewed
2019-03-03
Date
2015-10-19
Topics
Ethics and medical professionalism
Policy Type
Parliamentary submission
Last Reviewed
2019-03-03
Date
2015-10-19
Topics
Ethics and medical professionalism
Documents
Less detail

Palliative care

https://policybase.cma.ca/link/policy11809
Last Reviewed
2020-02-29
Date
2015-10-03
Topics
Ethics and medical professionalism
Policy Type
Policy document
Last Reviewed
2020-02-29
Date
2015-10-03
Topics
Ethics and medical professionalism
Documents
Less detail

Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.

https://policybase.cma.ca/link/policy11814
Date
2016-01-20
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Health care and patient safety

Consultation on the prescription drug list: Naloxone

https://policybase.cma.ca/link/policy11847
Date
2016-03-19
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Legalization, regulation and restriction of access to marijuana

https://policybase.cma.ca/link/policy11954
Date
2016-08-29
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Statement to the Canadian panel on violence against women Ottawa -September, 1992

https://policybase.cma.ca/link/policy11956
Last Reviewed
2019-03-03
Date
1992-09-15
Topics
Health care and patient safety
Ethics and medical professionalism
Policy Type
Parliamentary submission
Last Reviewed
2019-03-03
Date
1992-09-15
Topics
Health care and patient safety
Ethics and medical professionalism
Documents
Less detail

103 records – page 2 of 6.